Designing Multivalent Ligands to Control Biological Interactions: From Vaccines and Cellular Effectors to Targeted Drug Delivery
Multivalent interactions in which multiple ligands on one object bind to multiple receptors on another are commonly found in natural biological systems. In addition, these interactions can lead to increased strength and selectivity when compared to the corresponding monovalent interaction. These att...
Gespeichert in:
| Veröffentlicht in: | Chemistry, an Asian journal an Asian journal, 2019-01, Vol.14 (2), p.244-255 |
|---|---|
| Hauptverfasser: | , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 255 |
|---|---|
| container_issue | 2 |
| container_start_page | 244 |
| container_title | Chemistry, an Asian journal |
| container_volume | 14 |
| creator | Arsiwala, Ammar Castro, Ana Frey, Steven Stathos, Mark Kane, Ravi S. |
| description | Multivalent interactions in which multiple ligands on one object bind to multiple receptors on another are commonly found in natural biological systems. In addition, these interactions can lead to increased strength and selectivity when compared to the corresponding monovalent interaction. These attributes have also guided the design of synthetic multivalent ligands to control biological interactions. This review will highlight the recent literature describing the use of multivalent ligand display in the design of vaccines, immunomodulators, cell signaling effectors, and vehicles for targeted drug delivery.
By design: While multivalent interactions, in which multiple ligands on one object bind to multiple receptors on another, are commonly found in nature, there is also significant interest in designing multivalent ligands to control biological interactions. This review primarily focuses on recent applications of multivalency in the design of vaccines, immunomodulators, cell signaling effectors, and vehicles for targeted drug delivery. |
| doi_str_mv | 10.1002/asia.201801677 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2155944885</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2168093654</sourcerecordid><originalsourceid>FETCH-LOGICAL-c5167-527c7d0e0b03a16fda33a42ae655fb36d29514c8cbfc79c4f3cf4615781080cd3</originalsourceid><addsrcrecordid>eNqFkU1vEzEQhi0EoqVw5YgsceGS4I-118stTVqIFMSBgritHO945cqxi-0tyo2fXrcpQeLCaebwvI9m9CL0mpI5JYS919npOSNUESrb9gk6pUrSWdPSH0-PO1Mn6EXO14QIRjr1HJ3wunHZslP0ewXZjcGFEX-efHG32kMoeONGHYaMS8TLGEqKHp-76OPojPZ4HQokbYqLIX_Alynu8HdtjAuQcY3hJXg_eZ3whbVgSkwPoiudRigw4FWaRrwC724h7V-iZ1b7DK8e5xn6dnlxtfw023z5uF4uNjMj6mczwVrTDgTIlnBNpR0057phGqQQdsvlwDpBG6PM1pq2M43lxjaSilZRoogZ-Bl6d_DepPhzglz6ncumHqoDxCn3jArRNY1SoqJv_0Gv45RCva5SUpGOS9FUan6gTIo5J7D9TXI7nfY9Jf19N_19N_2xmxp486idtjsYjvifMirQHYBfzsP-P7p-8XW9-Cu_A30wnB8</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2168093654</pqid></control><display><type>article</type><title>Designing Multivalent Ligands to Control Biological Interactions: From Vaccines and Cellular Effectors to Targeted Drug Delivery</title><source>Wiley Journals</source><creator>Arsiwala, Ammar ; Castro, Ana ; Frey, Steven ; Stathos, Mark ; Kane, Ravi S.</creator><creatorcontrib>Arsiwala, Ammar ; Castro, Ana ; Frey, Steven ; Stathos, Mark ; Kane, Ravi S.</creatorcontrib><description>Multivalent interactions in which multiple ligands on one object bind to multiple receptors on another are commonly found in natural biological systems. In addition, these interactions can lead to increased strength and selectivity when compared to the corresponding monovalent interaction. These attributes have also guided the design of synthetic multivalent ligands to control biological interactions. This review will highlight the recent literature describing the use of multivalent ligand display in the design of vaccines, immunomodulators, cell signaling effectors, and vehicles for targeted drug delivery.
By design: While multivalent interactions, in which multiple ligands on one object bind to multiple receptors on another, are commonly found in nature, there is also significant interest in designing multivalent ligands to control biological interactions. This review primarily focuses on recent applications of multivalency in the design of vaccines, immunomodulators, cell signaling effectors, and vehicles for targeted drug delivery.</description><identifier>ISSN: 1861-4728</identifier><identifier>EISSN: 1861-471X</identifier><identifier>DOI: 10.1002/asia.201801677</identifier><identifier>PMID: 30523672</identifier><language>eng</language><publisher>Germany: Wiley Subscription Services, Inc</publisher><subject>cell signaling ; Chemistry ; Displays ; Drug delivery systems ; Effectors ; Immunomodulators ; Ligands ; multivalency ; Receptors ; Selectivity ; targeted delivery ; Vaccines</subject><ispartof>Chemistry, an Asian journal, 2019-01, Vol.14 (2), p.244-255</ispartof><rights>2019 Wiley‐VCH Verlag GmbH & Co. KGaA, Weinheim</rights><rights>2018 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c5167-527c7d0e0b03a16fda33a42ae655fb36d29514c8cbfc79c4f3cf4615781080cd3</citedby><cites>FETCH-LOGICAL-c5167-527c7d0e0b03a16fda33a42ae655fb36d29514c8cbfc79c4f3cf4615781080cd3</cites><orcidid>0000-0003-3084-4098</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1002%2Fasia.201801677$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1002%2Fasia.201801677$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,780,784,1417,27924,27925,45574,45575</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/30523672$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Arsiwala, Ammar</creatorcontrib><creatorcontrib>Castro, Ana</creatorcontrib><creatorcontrib>Frey, Steven</creatorcontrib><creatorcontrib>Stathos, Mark</creatorcontrib><creatorcontrib>Kane, Ravi S.</creatorcontrib><title>Designing Multivalent Ligands to Control Biological Interactions: From Vaccines and Cellular Effectors to Targeted Drug Delivery</title><title>Chemistry, an Asian journal</title><addtitle>Chem Asian J</addtitle><description>Multivalent interactions in which multiple ligands on one object bind to multiple receptors on another are commonly found in natural biological systems. In addition, these interactions can lead to increased strength and selectivity when compared to the corresponding monovalent interaction. These attributes have also guided the design of synthetic multivalent ligands to control biological interactions. This review will highlight the recent literature describing the use of multivalent ligand display in the design of vaccines, immunomodulators, cell signaling effectors, and vehicles for targeted drug delivery.
By design: While multivalent interactions, in which multiple ligands on one object bind to multiple receptors on another, are commonly found in nature, there is also significant interest in designing multivalent ligands to control biological interactions. This review primarily focuses on recent applications of multivalency in the design of vaccines, immunomodulators, cell signaling effectors, and vehicles for targeted drug delivery.</description><subject>cell signaling</subject><subject>Chemistry</subject><subject>Displays</subject><subject>Drug delivery systems</subject><subject>Effectors</subject><subject>Immunomodulators</subject><subject>Ligands</subject><subject>multivalency</subject><subject>Receptors</subject><subject>Selectivity</subject><subject>targeted delivery</subject><subject>Vaccines</subject><issn>1861-4728</issn><issn>1861-471X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><recordid>eNqFkU1vEzEQhi0EoqVw5YgsceGS4I-118stTVqIFMSBgritHO945cqxi-0tyo2fXrcpQeLCaebwvI9m9CL0mpI5JYS919npOSNUESrb9gk6pUrSWdPSH0-PO1Mn6EXO14QIRjr1HJ3wunHZslP0ewXZjcGFEX-efHG32kMoeONGHYaMS8TLGEqKHp-76OPojPZ4HQokbYqLIX_Alynu8HdtjAuQcY3hJXg_eZ3whbVgSkwPoiudRigw4FWaRrwC724h7V-iZ1b7DK8e5xn6dnlxtfw023z5uF4uNjMj6mczwVrTDgTIlnBNpR0057phGqQQdsvlwDpBG6PM1pq2M43lxjaSilZRoogZ-Bl6d_DepPhzglz6ncumHqoDxCn3jArRNY1SoqJv_0Gv45RCva5SUpGOS9FUan6gTIo5J7D9TXI7nfY9Jf19N_19N_2xmxp486idtjsYjvifMirQHYBfzsP-P7p-8XW9-Cu_A30wnB8</recordid><startdate>20190118</startdate><enddate>20190118</enddate><creator>Arsiwala, Ammar</creator><creator>Castro, Ana</creator><creator>Frey, Steven</creator><creator>Stathos, Mark</creator><creator>Kane, Ravi S.</creator><general>Wiley Subscription Services, Inc</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>K9.</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0003-3084-4098</orcidid></search><sort><creationdate>20190118</creationdate><title>Designing Multivalent Ligands to Control Biological Interactions: From Vaccines and Cellular Effectors to Targeted Drug Delivery</title><author>Arsiwala, Ammar ; Castro, Ana ; Frey, Steven ; Stathos, Mark ; Kane, Ravi S.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c5167-527c7d0e0b03a16fda33a42ae655fb36d29514c8cbfc79c4f3cf4615781080cd3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2019</creationdate><topic>cell signaling</topic><topic>Chemistry</topic><topic>Displays</topic><topic>Drug delivery systems</topic><topic>Effectors</topic><topic>Immunomodulators</topic><topic>Ligands</topic><topic>multivalency</topic><topic>Receptors</topic><topic>Selectivity</topic><topic>targeted delivery</topic><topic>Vaccines</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Arsiwala, Ammar</creatorcontrib><creatorcontrib>Castro, Ana</creatorcontrib><creatorcontrib>Frey, Steven</creatorcontrib><creatorcontrib>Stathos, Mark</creatorcontrib><creatorcontrib>Kane, Ravi S.</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>MEDLINE - Academic</collection><jtitle>Chemistry, an Asian journal</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Arsiwala, Ammar</au><au>Castro, Ana</au><au>Frey, Steven</au><au>Stathos, Mark</au><au>Kane, Ravi S.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Designing Multivalent Ligands to Control Biological Interactions: From Vaccines and Cellular Effectors to Targeted Drug Delivery</atitle><jtitle>Chemistry, an Asian journal</jtitle><addtitle>Chem Asian J</addtitle><date>2019-01-18</date><risdate>2019</risdate><volume>14</volume><issue>2</issue><spage>244</spage><epage>255</epage><pages>244-255</pages><issn>1861-4728</issn><eissn>1861-471X</eissn><abstract>Multivalent interactions in which multiple ligands on one object bind to multiple receptors on another are commonly found in natural biological systems. In addition, these interactions can lead to increased strength and selectivity when compared to the corresponding monovalent interaction. These attributes have also guided the design of synthetic multivalent ligands to control biological interactions. This review will highlight the recent literature describing the use of multivalent ligand display in the design of vaccines, immunomodulators, cell signaling effectors, and vehicles for targeted drug delivery.
By design: While multivalent interactions, in which multiple ligands on one object bind to multiple receptors on another, are commonly found in nature, there is also significant interest in designing multivalent ligands to control biological interactions. This review primarily focuses on recent applications of multivalency in the design of vaccines, immunomodulators, cell signaling effectors, and vehicles for targeted drug delivery.</abstract><cop>Germany</cop><pub>Wiley Subscription Services, Inc</pub><pmid>30523672</pmid><doi>10.1002/asia.201801677</doi><tpages>12</tpages><orcidid>https://orcid.org/0000-0003-3084-4098</orcidid><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1861-4728 |
| ispartof | Chemistry, an Asian journal, 2019-01, Vol.14 (2), p.244-255 |
| issn | 1861-4728 1861-471X |
| language | eng |
| recordid | cdi_proquest_miscellaneous_2155944885 |
| source | Wiley Journals |
| subjects | cell signaling Chemistry Displays Drug delivery systems Effectors Immunomodulators Ligands multivalency Receptors Selectivity targeted delivery Vaccines |
| title | Designing Multivalent Ligands to Control Biological Interactions: From Vaccines and Cellular Effectors to Targeted Drug Delivery |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-04T18%3A51%3A48IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Designing%20Multivalent%20Ligands%20to%20Control%20Biological%20Interactions:%20From%20Vaccines%20and%20Cellular%20Effectors%20to%20Targeted%20Drug%20Delivery&rft.jtitle=Chemistry,%20an%20Asian%20journal&rft.au=Arsiwala,%20Ammar&rft.date=2019-01-18&rft.volume=14&rft.issue=2&rft.spage=244&rft.epage=255&rft.pages=244-255&rft.issn=1861-4728&rft.eissn=1861-471X&rft_id=info:doi/10.1002/asia.201801677&rft_dat=%3Cproquest_cross%3E2168093654%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2168093654&rft_id=info:pmid/30523672&rfr_iscdi=true |